]>
IRCT20190606043826N1 IRCT 2019-06-24 Kashan University of Medical Sciences Comparison of levofloxacin versus clarithromycin efficacytherapy for helicobacter pylori eradication Comparison of levofloxacin versus clarithromycin efficacy in bismuth-containing quadruple therapy for helicobacter pylori eradication 2019-06-05 anticipated 194 Complete https://irct.ir/trial/40014 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention. N/A Helicobacter pylori. Intervention 1: The intervention group was as follows treated with 4 doses of bismuth substrate (2 tablets every 12 hours), omeprazole (20 mg every 12 hours),amoxicillin (1 g every 12 hours) Clarithromycin (500 mg every 12 hours). Intervention 2: The intervention group : treated with 4 drugs including bismuth subcetate (2 tablets every 6 hours), omeprazole (20 mg every 12 hours), amoxicillin (1 g every 12 hours) Levofloxacin (500 mg every 12 hours). Yes - There is a plan to make this available What will be shared: Part of the data relating to the Helicobacter counts can be shared. When: After analyzing the results, the data access period is free. To whom: Academic Institutions and Researchers Conditions: For use in future studies. Where to obtain: Corresponding Author How to obtain: Send an email to the author and get the information Comments:
public Abbas Arj
Kashan university of medical sciences, Qotbe Ravandi Blvd, Kashan
Kashan Iran (Islamic Republic of) 8711111111 +98 31 5550 0111 Dr_Arj@yahoo.com Kashan University of Medical Sciences scientific Abbas Arj
Kashan university of medical sciences, Qotbe Ravandi Blvd, Kashan
Kashan Iran (Islamic Republic of) 8711111111 +98 31 5550 0111 Dr_Arj@yahoo.com Kashan University of Medical Sciences Iran (Islamic Republic of) Positive h.pylori people have indications of treatment Age between 14 and 70 years Patients with informed consent to participate in the study 14 years 70 years Both Do not use the correct and regular drug Incidence of unbearable side effects Pregnancy and lactation The presence of chronic liver, kidney and gastrointestinal diseases simultaneously Previous history of h.pylori treatment in a recent month B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters Treatment - Drugs Treatment - Drugs The intervention group was as follows treated with 4 doses of bismuth substrate (2 tablets every 12 hours), omeprazole (20 mg every 12 hours),amoxicillin (1 g every 12 hours) Clarithromycin (500 mg every 12 hours) The intervention group : treated with 4 drugs including bismuth subcetate (2 tablets every 6 hours), omeprazole (20 mg every 12 hours), amoxicillin (1 g every 12 hours) Levofloxacin (500 mg every 12 hours) The presence or absence of stool antigen,. Timepoint: At the end of the first and second weeks of treatment. Method of measurement: Fecal antigen test to confirm eradication of infection. Incidence or absence of drug side effects. Timepoint: At the end of the first and second weeks of treatment. Method of measurement: questionnaire. Kashan University of Medical Sciences Approved 2018-05-27 Faculty of Medicine and Dentistry- Kashan University of Medical Sciences Kashan University of Medical Sciences Kashan Isfehan Iran (Islamic Republic of)